CAS Shanghai Institute Pasteur develops influenza vaccine manufactured in Vero cells

The PR8 virus was adapted to Vero cells by continuous passaging, resulting in a Vero-adapted, high-yield PR8-4mut virus as a promising candidate for an influenza-vaccine donor virus

CAS news release, Dec. 31, 2014

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny